Aztreonam-Avibactam in Immunocompromised Hosts | MicrobiomeTrials← Back to trialsNCT07890480
Aztreonam-Avibactam in Immunocompromised Hosts
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-10-14Est. Completion: 2028-11-01
Enrollment target: 814 participants Locations- CEMIC - Centro de Educación Médica e Investigaciones Clínicas "Dr. Norberto Quirno", Buenos Aires, City of Buenos Aires, Argentina
Other microbiome trials you might be interested in
Diarrhoea
This study evaluates the immune response and safety of a multicomponent, 2-dose Shigella vaccine in preventing shigellos…
Kericho, KenyaCompleted Oct 21, 2025
Liver TransplantationCarbapenem-Resistant Enterobacteriaceae Colonization
Although CRE infection after OLT have a dramatic impact on patient survival and several implementations have been propos…
São Paulo, BrazilCompleted Oct 31, 2024
Phase 4
Recruiting
Blood Stream InfectionsVentilator Associated PneumoniaHealthcare Associated InfectionCarbapenem-Resistant Enterobacteriaceae InfectionHospital-acquired Pneumonia
RAPID is an investigator initiated Phase 4, multinational, multicentre, open-label, randomised controlled superiority tr…
Vellore, IndiaEst. completion Oct 31, 2027